Wednesday, 01 January 2025

Main

Information
Last updated: 29 December 2024

Transcranial Magnetic Stimulation (TMS) in Autism Spectrum Disorders

Information
Autism Spectrum DisorderTranscranial Magnetic Stimulation
TMS presents a promising, non-invasive intervention for modulating neurophysiological abnormalities associated with ASD.

Autism Spectrum Disorder (ASD)

  • ASD is a neurodevelopmental disorder characterized by:
    • Difficulties in social communication and interaction
    • Restricted, repetitive patterns of behavior, interests, or activities
    • Sensory abnormalities
  • Highly heterogeneous in nature, with varying symptom expression and severity
  •  Prevalence: Approximately 1 in 54 children (CDC, 2020)
  • Etiology: Multifactorial, involving genetic and environmental factors
  • Neuropathology:
    • Abnormalities in brain development and neuronal migration
    • Cortical dysplasias and minicolumnar abnormalities
    • Alterations in gray-white matter boundaries

Mechanism of Transcranial Magnetic Stimulation (TMS)

  • Non-invasive brain stimulation technique
  • Based on Faraday’s law of electromagnetic induction
  • Key components:
    • Power supply and capacitors
    • Stimulating coil (figure-8 or circular)
  • Process:
    • Rapid discharge of current through the coil
    • Generation of a time-varying magnetic field
    • Induction of electric currents in underlying neural tissue
    • Depth of penetration: Approximately 2-3 cm from the scalp
  • Types:
    • Single-pulse TMS
    • Paired-pulse TMS
    • Repetitive TMS (rTMS)
    • Low-frequency (≤1 Hz): Generally inhibitory
    • High-frequency (≥5 Hz): Generally excitatory

Observed Effects of TMS in ASD

  • A. Behavioral Changes
    • Reduction in repetitive and stereotypic behaviors
    • Improved social responsiveness
    • Enhanced error monitoring and correction
    • Decreased irritability and hyperactivity
  • B. Cognitive Functions
    • Improved executive functioning
    • Enhanced attention and working memory
    • Better response inhibition
    • Improved visual processing and perceptual binding
  • C. Neurophysiological Effects
    • Modulation of cortical excitability
    • Normalization of gamma oscillations
    • Altered connectivity patterns (local and long-range)
    • Changes in event-related potentials (ERPs)

Treatment Specifics

  • Target areas:
    • Dorsolateral prefrontal cortex (DLPFC)
    • Inferior parietal lobule
    • Temporoparietal junction
  • Protocols:
    • Low-frequency rTMS (e.g., 1 Hz) to DLPFC
    • High-frequency rTMS (e.g., 5-20 Hz) to various regions
    • Duration: Typically 2-6 weeks, with daily or alternate-day sessions
    • Session length: 20-40 minutes
    • Number of pulses: 1000-3000 per session

Neurophysiological Basis

  • Cortical inhibitory imbalance in ASD:
    • Reduced GABAergic inhibition
    • Altered excitatory/inhibitory (E/I) balance
  • Gamma oscillations (30-80 Hz):
    • Associated with cognitive functions often impaired in ASD
    • Abnormal in ASD (often increased power and reduced discrimination)
  • Parvalbumin-positive interneurons:
    • Crucial for generating gamma oscillations
    • Reduced in number in ASD
  • TMS effects on neural circuits:
    • Modulation of local and long-range connectivity
    • Potential normalization of E/I balance
    • Alteration of synaptic plasticity

Safety and Effectiveness

  • Generally considered safe when applied within established guidelines
  • Common side effects:
    • Headache
    • Scalp discomfort
    • Transient changes in hearing
  • Rare but serious risks:
    • Seizures (risk < 1% in normal populations)
  • Effectiveness:
    • Promising results in multiple studies
    • Variability in individual responses
    • Long-term effects still under investigation

Recent Studies and Significant Findings

  • Casanova et al. (2020):
    • Low-frequency rTMS to DLPFC decreased gamma power
    • Increased differentiation between target and non-target stimuli
    • Improved executive function and self-monitoring behaviors
  • Afshari et al. (2024):
    • High-frequency rTMS in animal model of ASD
    • Reduced oxidative stress and improved biochemical factors
    • Increased dendritic spine density in hippocampus
  • Yang et al. (2023):
    • rTMS strengthened long-range feedback connections
    • Weakened short-range connections
    • Corresponded with improvement in core ASD symptoms
  • Sokhadze et al. (2018):
    • rTMS improved error monitoring (ERN) and post-error reaction time
    • Reduced repetitive behaviors and irritability
  • Ni et al. (2017):
    • Theta-burst stimulation to DLPFC and posterior superior temporal sulcus
    • Improved social relating and motivation

Future Research Directions

  • Large-scale, multi-site clinical trials
  • Optimization of stimulation parameters:
    • Frequency, intensity, duration, and target locations
  • Combination therapies:
    • TMS with behavioral interventions
    • TMS with neurofeedback
  • Personalized medicine approaches:
    • Genetic profiling to predict responders
    • Neuroimaging-guided targeting
  • Long-term follow-up studies:
    • Durability of effects
    • Need for maintenance sessions
  • Investigation of age-dependent effects:
    • Optimal timing for intervention
    • Safety and efficacy in younger children
  • Exploration of novel stimulation paradigms:
    • Theta-burst stimulation
    • Quadripulse stimulation
    • Development of home-based TMS devices for more frequent application

Conclusion

  • TMS shows promise as a therapeutic intervention for ASD
  • Targets core pathophysiological features (e.g., E/I imbalance, gamma abnormalities)
  • Demonstrates improvements in behavior, cognition, and neurophysiology
  • Further research needed to optimize protocols and understand long-term effects
  • Potential to become an important tool in the multimodal treatment of ASD

References

  • Casanova, M. F., Shaban, M., Ghazal, M., El-Baz, A. S., Casanova, E. L., Opris, I., & Sokhadze, E. M. (2020). Effects of transcranial magnetic stimulation therapy on evoked and induced gamma oscillations in children with autism spectrum disorder. Brain Sciences10(7), 423. doi:10.3390/brainsci10070423
  • Afshari, M., Gharibzadeh, S., Pouretemad, H., & Roghani, M. (2024). Promising therapeutic effects of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in addressing autism spectrum disorder induced by valproic acid. Frontiers in Neuroscience18, 1385488. doi:10.3389/fnins.2024.1385488
  • Yang, Y., Jiang, L., He, R., Song, P., Xu, P., Wang, Y., & Li, F. (2023). Repetitive transcranial magnetic stimulation modulates long-range functional connectivity in autism spectrum disorder. Journal of Psychiatric Research160, 187–194. doi:10.1016/j.jpsychires.2023.02.021
  • Ni, H.-C., Hung, J., Wu, C.-T., Wu, Y.-Y., Chang, C.-J., Chen, R.-S., & Huang, Y.-Z. (2017). The impact of single session intermittent theta-burst stimulation over the dorsolateral prefrontal cortex and posterior superior temporal sulcus on adults with autism spectrum disorder. Frontiers in Neuroscience11, 255. doi:10.3389/fnins.2017.00255
  • Sokhadze EM, Lamina EV, Casanova EL, et al: Exploratory study of rTMS neuomodulation effects on electrocortical functional measures of performance in an oddball test and behavioral symptoms of autism. Front Syst Neurosci 12:20, 2018

Related Articles

Metabolic derangements and Autism